Last update:

Oncology & Cancer news

Oncology & Cancer

HLA-DRB1 molecule offers potential target for CAR therapy in relapsed acute myeloid leukemia post-transplantation

One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many drugs are designed to target tumor-specific antigens, which are molecules only expressed by cancer ...

Oncology & Cancer

High-fat diet promotes breast cancer metastasis in animal models

Obesity is associated with an increased risk of developing breast cancer, and a greater probability for the cancer to spread to other organs. But the causes of this association are still not well understood. Researchers at ...

Oncology & Cancer

Lung cancer screening lags behind breast and colorectal screenings

Lung cancer screening has the potential to catch lung cancer early and save lives—but only if people get screened. Although lung cancer screening is recommended in the U.S. for certain individuals with a history of smoking, ...

Oncology & Cancer

Combination approach to advanced cancer could improve survival

An international team of researchers, including experts from the University of Adelaide, has found genomic testing and targeted therapies for patients with advanced cancer could improve survival rates by up to 40%.

Oncology & Cancer

Advancements in ctDNA detection promise improved lymphoma outcomes

A research team led by Prof. Gu Hongcang from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has published a comprehensive systematic review on circulating tumor DNA (ctDNA) technologies and their ...

Oncology & Cancer

SOX9 as a prognostic marker in gastric adenocarcinoma

Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide, with more than one million new diagnoses annually. Unfortunately, many cases are detected at advanced stages due to the lack of clear early symptoms, ...

Medical research

Nanoparticles extend glioblastoma survival in phase one trial

Despite decades of research to develop effective treatments, the median survival for glioblastoma—the most common malignant primary brain tumor in adults—is just 15–18 months after diagnosis. One reason for this grim ...

Oncology & Cancer

Pregnant women face cancer diagnosis delays, study reveals

Cancer symptoms can sometimes be misdiagnosed as normal pregnancy-related changes for women who are expecting, in some cases leading to a delay in treatment, according to a new study from the University of Surrey.

Medical research

Research ties mouth cancer to oral microbiome shifts

Oral squamous cell cancer, or OSCC, arises in the cells that line the mouth. The disease is often diagnosed at a late stage, which comes with a poor prognosis, and 450,000 people die from it every year, according to the International ...

Oncology & Cancer

Urine-based test detects aggressive prostate cancer

Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being uncomfortable, some of these procedures result in overdiagnosis of low-grade cancers.

Oncology & Cancer

Uveal melanoma 3D models offer hope for improved treatments

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in adults. Their goal is to use these models to better understand how this disease works and develop ...

Oncology & Cancer

Novel lab-on-chip platform promises to expedite cancer diagnoses

Cancer accounted for nearly 10 million deaths in 2020—almost one in every six deaths globally—according to the World Health Organization. Because the detection of abnormal diseased cellular growth often occurs too late, ...